Education & TrainingCommercialMay 31, 2023

Building Vaccine Confidence – A webinar hosted by Pfizer

Join the webinar to empower vaccine confidence and address vaccine hesitancy by parents. Hear from Pfizer experts regarding effective vaccine communication to increase acceptance of vaccine recommendations for childhood and adolescent immunizations.

Learning objectives:

  • Learn about vaccine confidence basics
  • Key determinants of vaccine decision-making
  • Vaccine development and safety monitoring
  • Communication strategies and best practices

Webinar date and time:

  • Tuesday, June 20, 2023
  • 9 a.m. Pacific time/noon Eastern time

Playback of the webinar recording only available for two weeks.

Register at: https://event.on24.com/wcc/r/4205906/830289BB718AAD0D42DE89F0F917DA03
(Open link in Google Chrome for the best experience.)

Speakers:Antonio Jesús Iglesias, PharmD
Vaccines Medical Director
Pfizer

Antonio Jesús Iglesias, PharmD, is a Vaccines Medical Director, Pfizer US Medical Affairs/Vaccines Medical Development and Scientific Affairs. Dr. Iglesias is committed to making a difference in geographies that include children and adults with disproportionate vaccination rates. He has over 30 years of healthcare-related experience in various sectors, including the pharmaceutical industry, academia, managed care organizations, and government. He received a BS degree in Chemical Engineering and a Doctor of Pharmacy degree from the University of Florida. He also completed a Pharmacy Practice Residency in Pediatrics at the University of Florida/Jackson Memorial Health System in Miami.

Dr. Mateu-Petit
Vaccines Medical Director
Pfizer

Dr. Mateu-Petit is a Vaccines Medical Director at Pfizer. She has expertise in the areas of virology, molecular biology, cell biology, immunology, vaccine-preventable diseases, vaccine clinical trials, and epidemiology of infectious diseases. She joined the Medical Affairs Department after 12 years of academic career. She transitioned to the private sector from the Influenza Division at the Centers for Disease Control and Prevention where her research was focused on the development, characterization, and evaluation of novel and seasonal influenza candidate vaccine viruses. Since then, her efforts have been dedicated to the field of vaccinology.



CPN-CM-026395-23

PUBLICATIONS: June 2023 Provider Newsletter